thermogenesis holdings, inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (car)-t and other cell-based therapies. it markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed car-txpress platform, which streamlines the manufacturing process for the emerging car-t immunotherapy market. the company operates through two segments, device and clinical development. it manufactures and markets products for clinical bio-banking applications, including axp automated cell separation system, an automated cell separation system for isolating and retrieving stem and progenitor cells from umbilical cord blood; and bioarchive automated cryopreservation system, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical appli
Company profile
Ticker
THMO
Exchange
Website
CEO
Xiaochun Xu
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Misonix • Reflect Scientific ...
Former names
CESCA THERAPEUTICS INC., THERM0GENESIS CORP, THERMOGENESIS CORP
SEC CIK
Corporate docs
Subsidiaries
ThermoGenesis Corp. • Wholly-owned by ThermoGenesis Holdings, Inc. • CARTXpress Bio Inc. ...
IRS number
943018487
THMO stock data
Latest filings (excl ownership)
NT 10-Q
Notice of late quarterly filing
15 Aug 24
8-K
Changes in Registrant's Certifying Accountant
6 Aug 24
8-K
Departure of Directors or Certain Officers
16 Jul 24
8-K
Other Events
16 Jul 24
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
10 Jul 24
8-K
Other Events
2 Jul 24
25-NSE
Exchange delisting
28 Jun 24
8-K
Departure of Directors or Certain Officers
26 Jun 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11 Jun 24
8-K
Other Events
4 Jun 24
Transcripts
THMO
Earnings call transcript
2023 Q3
13 Nov 23
THMO
Earnings call transcript
2023 Q2
10 Aug 23
THMO
Earnings call transcript
2023 Q1
15 May 23
THMO
Earnings call transcript
2022 Q4
30 Mar 23
THMO
Earnings call transcript
2022 Q3
12 Nov 22
THMO
Earnings call transcript
2022 Q2
13 Aug 22
THMO
Earnings call transcript
2022 Q1
19 May 22
THMO
Earnings call transcript
2021 Q4
28 Mar 22
THMO
Earnings call transcript
2021 Q3
13 Nov 21
THMO
Earnings call transcript
2021 Q2
13 Aug 21
Latest ownership filings
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.18 mm | 1.18 mm | 1.18 mm | 1.18 mm | 1.18 mm | 1.18 mm |
Cash burn (monthly) | 274.67 k | 389.83 k | 185.67 k | 676.83 k | 168.33 k | 300.92 k |
Cash used (since last report) | 1.85 mm | 2.62 mm | 1.25 mm | 4.55 mm | 1.13 mm | 2.02 mm |
Cash remaining | -670.23 k | -1.44 mm | -72.00 k | -3.37 mm | 44.51 k | -846.68 k |
Runway (months of cash) | -2.4 | -3.7 | -0.4 | -5.0 | 0.3 | -2.8 |
Institutional ownership, Q1 2024
13F holders | Current |
---|---|
Total holders | 4 |
Opened positions | 0 |
Closed positions | 2 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 38.58 mm |
Total shares | 62.84 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Boyalife Asset Holding II | 49.80 mm | $10.57 mm |
Boyalife | 7.54 mm | $7.72 mm |
Foley & LARDNER/ Fa | 2.76 mm | $10.14 mm |
Xu Xiaochun | 2.76 mm | $10.14 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Jun 24 | Xu Xiaochun | Common Stock | Conversion | Acquire C | Yes | No | 0.38 | 7,894,737 | 3.00 mm | 12,335,016 |
28 Jun 24 | Xu Xiaochun | Amendment 4 to 1st Amended & Restated Revolving Credit Agr. Common Stock | Conversion | Dispose C | Yes | No | 0.38 | - | 3.00 mm | - |
15 Mar 24 | Xu Xiaochun | Common Stock | Conversion | Acquire C | Yes | No | 0.38 | 4,113,158 | 1.56 mm | 4,440,279 |
15 Mar 24 | Xu Xiaochun | Amendment 4 to 1st Amended & Restated Revolving Credit Agr. Common Stock | Conversion | Dispose C | Yes | No | 0.38 | - | 1.56 mm | - |
17 Nov 23 | Xu Xiaochun | Common Stock | Sell | Dispose S | Yes | No | 1.02 | 600,000 | 612.00 k | 327,121 |
28 Sep 23 | Xu Xiaochun | Common Stock | Conversion | Acquire C | Yes | No | 1.07 | 654,206 | 700.00 k | 927,121 |
28 Sep 23 | Xu Xiaochun | Amendment 3 to 1st Amended & Restated Revolving Credit Agr. Common Stock | Conversion | Dispose C | Yes | No | 1.07 | - | 700.00 k | - |